LQDA
Liquidia Corp
NASDAQ · Pharmaceuticals
$43.04
+1.48 (+3.56%)
Performance
1D
—
1W
-2.65%
1M
+17.60%
3M
+54.93%
6M
+70.79%
1Y
+165.35%
YTD
+37.07%
Open$42.65
Previous Close$41.56
Day High$43.89
Day Low$41.79
52W High$46.67
52W Low$11.26
Volume1.50M
Avg Volume1.76M
Market Cap3.74B
P/E Ratio—
EPS$-1.43
SectorPharmaceuticals
Volume Analysis
0.85x average volume
Technical Indicators
SMA 50
$36.46
Above
SMA 200
$24.52
Above
RSI (14)
63.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+0.3% upside
Current
$43.04
$43.04
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 15.47M | 15.03M | 825.78M |
| Net Income | -144,125,417 | -126,069,467 | 159.71M |
| Profit Margin | -931.7% | -885.1% | 19.3% |
| EBITDA | -138,688,199 | -128,053,055 | 249.33M |
| Free Cash Flow | — | — | 104.32M |
| Rev Growth | +2.9% | +2.9% | -2.7% |
| Debt/Equity | 1.49 | 1.49 | 1.04 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |